They undergo either enzymatic (nucleases and RNAse) or chemical (oxidation and hydrolysis) degradation in the blood and tissue fluids or are filtered and cleared by the kidneys
Other important safety considerations include hypoglycemia risk when combined with insulin or sulfonylureas, suicidal ideation (monitor for mood changes), and contraindication during pregnancy
Positioning GLP 1 RAs as Lifestyle Optimization Tools GLP-1 RA drugs were initially developed for individuals with obesity and type 2 diabetes, but their reach has extended far beyond this population
It is often used as a support tool rather than a primary driver of change
The magnitude of these changes varies based on dose, subject characteristics, and concurrent factors like training and nutrition, often documented in research as igf1 lr3 results and igf1 lr3 before and after comparisons
S7A, Supplementary Data 9)